Sign inJoin waitlistJoin the waitlist

HS

Howard Sofen

Physician · Howard L Sofen MD A Medical Corporation

Credentials: · · ·

History

Howard L Sofen MD A Medical Corporation
Present

Dermatology
University of California-Los Angeles
1982–1985
Preliminary or Transitional Year
1981–1982
HAHNEMANN UNIV SCH OF MED, PHILADELPHIA
1977–1981

Research

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and…
The Lancet · 2018 · 546 citations
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging…
The Lancet · 2016 · 474 citations
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
New England Journal of Medicine · 2017 · 413 citations

AB
Andrew Blauvelt
19 papers
Mark Lebwohl
13 papers
Bruce Strober
9 papers
JB
Jerry Bagel
8 papers
Stephen Tyring
7 papers
SB
Subhashis Banerjee
7 papers
Kenneth Gordon
6 papers
LG
Linda Stein Gold
6 papers
April Armstrong
5 papers
PR
Phoebe Rich
5 papers
Alice Gottlieb
4 papers
Eric Simpson
4 papers